biotech.today

Details

  • ●Modalities: small molecules
  • ●Therapeutic areas: neurodegeneration
  • ●Key targets: PIKfyve
  • ●Indications: ALS, Parkinson's
  • ●Funding: $98M

Partners & investors

  • Eli Lilly· Investor

Key considerations

  • ●AI tools in use: CONVERGE Platform
  • ●$98M Series B (2021)
  • ●Eli Lilly partnership

Pipeline

  • Phase 11
Get live updates on Verge Genomics’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Alice Zhang

Co-Founder & CEO

neuroscienceai-target-discovery
Visit website →LinkedIn →